lisofylline has been researched along with Cancer of Ovary in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Husain, A; Rosales, N; Schwartz, GK; Spriggs, DR | 1 |
1 other study(ies) available for lisofylline and Cancer of Ovary
| Article | Year |
|---|---|
Lisofylline sensitizes p53 mutant human ovarian carcinoma cells to the cytotoxic effects of cis-diamminedichloroplatinum (II).
Topics: Adjuvants, Immunologic; Cisplatin; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Genes, p53; Humans; Mutation; Ovarian Neoplasms; Pentoxifylline; Tumor Cells, Cultured | 1998 |